Journal article
Radiobiological evaluation of organs at risk for electronic high-dose-rate brachytherapy in uveal melanoma: a radiobiological modeling study
Journal of contemporary brachytherapy, Vol.13(5), pp.563-574
01/01/2021
DOI: 10.5114/jcb.2021.110349
PMCID: PMC8565628
PMID: 34759981
Abstract
Purpose: The objective of this study was to examine feasibility of single-or hypo-fraction of high-dose-rate (HDR) electronic brachytherapy (eBT) in uveal melanoma treatment.
Material and methods: Biologically effective doses (BED) of organs at risk (OARs) were compared to those of iodine-125-based eye plaque low-dose-rate brachytherapy (I-125 LDR-BT) with vitreous replacement (VR). Single-or hypo-fractionated equivalent physical doses (SFEDs or HFEDs) for tumor were calculated from tumor BED of I-125 LDR-BT using linear-quadratic (LQ) and universal survival curve (USC) models. BED OARs doses to retina opposite the implant, macula, optic disc, and lens were calculated and compared among SFED, HFED, and I-125 LDR-BT. Electronic BT of 50 kVp was considered assuming dose fall-off as clinically equivalent to I-125 LDR-BT. All OARs BEDs were analyzed with and without silicone oil VR.
Results: For a single-fraction incorporating VR, the median/interquartile range of LQ (USC)-based BED doses of the retina opposite the implant, macula, optic disc, and lens were 16%/1.2% (33%/4%), 35%/19.5% (64%/17.7%), 37%/19% (75%/17.8%), and 27%/7.9% (68%/23.2%) of those for I-125 LDR-BT, respectively. SFED tumor values were 29.8/0.2 Gy and 51.7/0.5 Gy when using LQ and USC models, respectively, which could be delivered within 1 hour. SFED can be delivered within 1 hour using a high-dose-rate eBT. Even four-fraction delivery of HFED without VR resulted in higher OARs doses in the macula, optic disc, and lens (135 similar to 159%) than when using I-125 LDR-BT technique. A maximum p-value of 0.005 was observed for these distributions.
Conclusions: The simulation of single-fraction eBT, including vitreous replacement, resulted in significantly re- duced OARs doses (16 similar to 75%) of that achieved with I-125 LDR-BT.
Details
- Title: Subtitle
- Radiobiological evaluation of organs at risk for electronic high-dose-rate brachytherapy in uveal melanoma: a radiobiological modeling study
- Creators
- Timothy J. Waldron - University of IowaBryan G. Allen - Roy J. and Lucille A. Carver College of MedicineEdward Pennington - University of IowaH. Culver Boldt - University of IowaYusung Kim - Roy J. and Lucille A. Carver College of Medicine
- Resource Type
- Journal article
- Publication Details
- Journal of contemporary brachytherapy, Vol.13(5), pp.563-574
- DOI
- 10.5114/jcb.2021.110349
- PMID
- 34759981
- PMCID
- PMC8565628
- NLM abbreviation
- J Contemp Brachytherapy
- ISSN
- 1689-832X
- eISSN
- 2081-2841
- Publisher
- Termedia Publishing House Ltd
- Number of pages
- 12
- Language
- English
- Date published
- 01/01/2021
- Academic Unit
- Radiation Oncology; Ophthalmology and Visual Sciences
- Record Identifier
- 9984312967602771
Metrics
14 Record Views